Related issues of hormone replacement therapy after treatment of gynecologic malignant tumorsTAN Rongrong, WU Jie471-475
Interpretation of updated domestic and foreign guidelines on menopause management and menopausal hormone therapyHUANG Feiling, CHEN Rong476-480
Interpretation on Consensus on the Diagnosis and Management of Polycystic Ovary Syndrome with Insulin ResistanceDING Leilei, TIAN Qinjie481-485
Interpretation of Expert Consensus on Issues Related to Abnormal Uterine Bleeding during PubertyYANG Xin486-490
Interpretation of Chinese Expert Consensus on Endocrine Therapy for Recurrent Endometrial Cancer(2024 Edition)CHEN Yao, WANG Zengying, WANG Yumeng, XIA Bairong491-495
A study on efficacy of ultrasound-guided stellate ganglion block combined with hormone replacement therapy in treatment of perimenopausal insomniaWAN Lun, ZONG Chujun, ZHAN Yucheng, LI Chenglong496-501
Correlation analysis of common menopause rating scales for Chinese womenYANG Lingjin, TANG Ruiyi, CHEN Rong502-507
Clinical efficacy and safety of allylestrenol in treatment of abnormal uterine bleeding due to ovulatory dysfunction in childbearing ageJIA Qiucheng, WEI Weiwei, CHEN Jiming, YU Yi, CHEN Wanying, LIU Chi, CAO Ying, XUE Wenpeng, XING Tingwei, LIU Junling, MIN Yifei508-512
A study on mechanism of anti-tumor natural product Garcinone E inhibiting autophagic flux in ovarian cancer cellsSUN Xuemei, LEI Shunmei, WANG Chunlai, DAI Yiping, WEI Dan, YIN Fuqiang, LIU Xia513-519
Observation on therapeutic effect of transurethral 1 470-nm wavelength laser prostatectomy with small-piece removal without morcellation in a tissue pulverizer for treatment of high-risk benign prostatic hyperplasiaLI Xiangping, TAO Yingxu, DENG Jiwang, LI Guobang, ZHONG Ruijuan, WEN Xingqiao520-524